16:29 EDT Imunon files $75M mixed securities shelf
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMNN:
- Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
- IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
- Imunon announces site activation for IMNN-101 Phase 1 vaccine study
- Imunon sees cash runway to end of 2024
- Imunon appoints Stacy Lindborg as president, CEO